The emerging threat of multidrug-resistant Gram-negative bacteria in urology

Hosam M. Zowawi(The University of Queensland), David L. Paterson(The University of Queensland), Deborah A. Williamson(University of Otago), Diletta Pezzani(University of Milan), Patrick N. A. Harris(University of Technology Sydney), Mark A. Schembri(The University of Queensland), Paul Anantharajah Tambyah(National University of Singapore), Matthew J. Roberts(The University of Queensland)

Nature Reviews Urology

September 1, 2015

10.1038/nrurol.2015.199

Cited by 367

Related Papers

Antimicrobial Resistance in ESKAPE Pathogens

|Clinical Microbiology Reviews|2020|2k

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

|JAMA|2018|761

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

|The Lancet Infectious Diseases|2017|521

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

|The Lancet Infectious Diseases|2021|338

Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

|The Lancet Infectious Diseases|2020|328